info@synchemia.com | sales@synchemia.com 
9766925136 
Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Related Products
N-Nitroso Lisinopril Impurity 8
| CAT No | SRC-N0143060 |
| CAS No | NA |
| Mol.F. | C25H33F3N4O7 |
| Mol.Wt. | 558.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Lisinopril Impurity 9
| CAT No | SRC-N0143061 |
| CAS No | NA |
| Mol.F. | C20H26F3N3O6 |
| Mol.Wt. | 461.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Lisinopril Impurity 11
| CAT No | SRC-N0143062 |
| CAS No | NA |
| Mol.F. | C20H24F3N3O7 |
| Mol.Wt. | 475.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso N-Carboxymethyl Lisinopril
| CAT No | SRC-N0143063 |
| CAS No | NA |
| Mol.F. | C23H32N4O8 |
| Mol.Wt. | 492.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity A
| CAT No | SRC-N0143064 |
| CAS No | NA |
| Mol.F. | C8H12ClN3O2 |
| Mol.Wt. | 217.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity B
| CAT No | SRC-N0143065 |
| CAS No | NA |
| Mol.F. | C14H11N5O2 |
| Mol.Wt. | 281.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity C
| CAT No | SRC-N0143066 |
| CAS No | NA |
| Mol.F. | C22H22ClN7O2 |
| Mol.Wt. | 451.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity D
| CAT No | SRC-N0143067 |
| CAS No | NA |
| Mol.F. | C8H10ClN3O2 |
| Mol.Wt. | 215.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity E
| CAT No | SRC-N0143068 |
| CAS No | NA |
| Mol.F. | C14H11N5O |
| Mol.Wt. | 265.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity F
| CAT No | SRC-N0143069 |
| CAS No | NA |
| Mol.F. | C25H28ClN7O2 |
| Mol.Wt. | 494.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity I
| CAT No | SRC-N0143070 |
| CAS No | NA |
| Mol.F. | C41H36ClN7O2 |
| Mol.Wt. | 694.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity J
| CAT No | SRC-N0143071 |
| CAS No | NA |
| Mol.F. | C24H24ClN7O3 |
| Mol.Wt. | 493.95 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity K
| CAT No | SRC-N0143072 |
| CAS No | NA |
| Mol.F. | C22H20ClN7O2 |
| Mol.Wt. | 449.90 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity L
| CAT No | SRC-N0143073 |
| CAS No | NA |
| Mol.F. | C44H43Cl2N13O2 |
| Mol.Wt. | 856.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan EP Impurity M
| CAT No | SRC-N0143074 |
| CAS No | NA |
| Mol.F. | C44H43Cl2N13O2 |
| Mol.Wt. | 856.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Losartan Acetyloxy Impurity
| CAT No | SRC-N0143075 |
| CAS No | NA |
| Mol.F. | C16H13N5O3 |
| Mol.Wt. | 323.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
